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Abstract
 
The leukocyte integrin lymphocyte function-associated antigen 1 (LFA-1) and its endothelial
ligand intercellular adhesion molecule (ICAM)-1 play an important role in transmigration as
demonstrated by in vivo and in vitro models of inflammation. Despite the prominent role, little
is known concerning the distribution and dynamic behavior of these adhesion molecules dur-
ing leukocyte transmigration. Therefore, we examined the spatial and temporal distribution of
LFA-1 on neutrophils actively transmigrating tumor necrosis factor-
 
 
 
–activated human umbil-
ical vein endothelial monolayers under shear flow. Upon neutrophil arrest, LFA-1 was evenly
distributed. However, once neutrophils initiated transmigration, LFA-1 rapidly redistributed to
form a ringlike cluster at the neutrophil–endothelial junctional interface through which trans-
migration occurred. As transmigration was completed, LFA-1 redistributed to the neutrophil
uropod. Endothelial ICAM-1 and JAM-A both colocalized with the ringlike LFA-1 cluster.
Further analysis of PMA-stimulated neutrophils, which increase mobility of LFA-1, showed a
rapid redistribution of LFA-1 and ICAM-1, but not endothelial JAM-A. Thus, endothelial
JAM-A does not appear to contribute to adhesion or transmigration in this system. This is the
first demonstration that neutrophil LFA-1 rapidly redistributes to form a ringlike structure that
coclusters with endothelial ICAM-1 as the neutrophil transmigrates.
Key words: inﬂammation • diapedesis • integrins • adhesion molecules • imaging
 
Introduction
 
A critical event during an inflammatory response is the re-
cruitment of blood leukocytes to the site of injury, immune
response, or infection. This process involves a sequential,
multistep adhesion cascade between leukocyte and endothe-
lial cell adhesion molecules that mediates leukocyte rolling,
firm adhesion, and transmigration of the endothelium (1).
Most in vitro experimental systems have found that the major-
ity of transmigration events occur at endothelial junctions (2,
3). Transmigrating leukocytes encounter multiple junctional
molecules and molecular complexes. CD99 and PECAM-1
are implicated in the transmigration of some but not all leu-
kocyte types (4). Several groups have also examined how
endothelial cell adherens junctions and tight junctions regu-
late passage of blood leukocytes (for review see reference 5).
More recently, our laboratory showed that adherent neutro-
phils and monocytes triggered focal gaps in VE-cadherin-
GFP (VE-cadGFP) through which the leukocytes migrated
(3, 6). Transmigration also occurred at sites of small preexist-
ing gaps in VE-cadGFP, which confirmed a previous paper
(7, 8). These findings provide a mechanism for trafficking
through endothelial adherens junctions and raise the ques-
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tion of how other molecules on both leukocytes and endo-
thelial cells behave during transmigration.
Although previous in vivo and in vitro studies have re-
vealed a critical role for the LFA-1–intercellular adhesion
molecule (ICAM)-1 ligand pair in leukocyte transmigration
(9–11), little is known concerning the physical location of
this adhesion pair during leukocyte transmigration. Here,
we investigated the distribution of neutrophil LFA-1 and
endothelial ICAM-1 in leukocyte transmigration by directly
visualizing these molecules in live cells under flow. These
techniques preserve the temporal sequence of events and
the spatial organization that can otherwise become altered
in tissues subjected to fixation, permeabilization, and stain-
ing with antibodies. This strategy also avoids postfixation
proteolysis of susceptible endothelial junctional proteins.
This paper is the first demonstration of changes in leukocyte
LFA-1 and endothelial cell ICAM-1 distribution during
neutrophil transmigration using live cell imaging. Our data
show that neutrophil LFA-1 undergoes rapid and dynamic
redistribution during the process of transmigration. LFA-1 is
rapidly redistributed to the site of contact at endothelial cell
junctions, where it forms a distinct ringlike cluster. Endo-
thelial ICAM-1 also becomes enriched at the LFA-1 rings,
and this LFA-1–ICAM-1 cluster remains around the neu-
trophil as it transmigrates. Our data suggest that the changes
in LFA-1 distribution reflect the molecular changes in LFA-1
affinity and avidity known to occur in integrin activation,
and adhesion to ligands such as ICAM-1 (12–14), and rep-
resent their physiological correlates during transmigration.
 
Materials and Methods
 
Materials. 
 
DPBS (Dulbecco’s PBS) with Ca
 
2
 
 
 
 and Mg
 
2
 
 
 
(DPBS
 
 
 
) or without (DPBS
 
 
 
) and M199 were purchased from
BioWhittaker Bioproducts. Recombinant hTNF-
 
 
 
 was pur-
chased from Genzyme. The working solution that gave the max-
imal response (25 ng/ml) contained 
 
 
 
10 pg/ml of endotoxin (3).
Human serum albumin (25% albuminate) was obtained from
Baxter Healthcare Corp. All other chemicals were of the highest
grade available from Baker Chemical.
 
Human Cell Culture and Leukocyte Isolation.
 
Pooled human
umbilical vein endothelial cells (HUVECs) were isolated and cul-
tured as described previously (15) with the following modifica-
tions: 2 mM glutamax (
 
l
 
-alanyl-
 
l
 
-glutamine; Invitrogen) was
substituted for glutamine and culture media (M199) was supple-
mented with 100 
 
 
 
M ascorbic acid and 100 nM hydrocortisone
(Sigma-Aldrich). The latter two components were supplemented
to physiological plasma concentrations and improved endothelial
cell barrier function (unpublished data). HUVEC monolayers
(subculture 2) were allowed to reach confluence and used in ex-
periments 48 h later. Human neutrophils were isolated from anti-
coagulated whole blood obtained from healthy volunteer donors
as described previously (16). The Brigham and Women’s Hospi-
tal Human Use Committee Board have approved all protocols
involving human subjects.
 
mAbs. 
 
The following mAbs have been reported previ-
ously and were used as purified IgG:nonblocking anti–JAM-A
(1H2A9; IgG1; reference 17); nonblocking anti–ICAM-1 mAb
CL23.4 was provided by S. Ferrone (Roswell Park Cancer Insti-
tute, Buffalo, NY; reference 18); nonblocking anti-CD11a/LFA-1
mAb TS2/4 (IgG1) was a gift from L. Klickstein (Brigham and
Women’s Hospital, Boston, MA; reference 19); anti–MHC-I
(W6/32; IgG2a; reference 20); blocking anti–VE-cadherin, clone
75 (Transduction Labs), and nonblocking control VE-cadherin,
TEA 1/31 were purchased commercially (Beckman Coulter).
1H2A9, W6/32, CL23.4, and TS2/4 mAb were conjugated to
fluorescent Alexa Fluor-488 or Alexa Fluor-568 using protein la-
beling kits as described by the manufacturer (Molecular Probes).
To stain live endothelial cells, confluent HUVEC monolayers
were incubated with Alexa-labeled mAb (0.5–2 
 
 
 
g per 25-mm
diameter glass coverslip) at 37
 
 
 
C for 5 min, rinsed immediately,
and inserted into the flow chamber. This mAb concentration re-
sulted in uniform labeling and had no effect on leukocyte adhe-
sion or transmigration, and did not alter endothelial cell perme-
ability (Fig. S1, available at http://www.jem.org/cgi/content/
full/jem.20040965/DC1). For labeling leukocytes, labeled mAb
(1–2 
 
 
 
g/ml) was added to leukocytes (5 
 
 
 
 10
 
6
 
 cells/ml), incu-
bated for 10 min at 8
 
 
 
C, and washed once before use.
 
Endothelial Cell Permeability Assay.
 
HUVECs were plated
onto gelatin-coated Costar transwell filters (2.5 
 
 
 
 10
 
4
 
 cells/filter)
and grown to confluence (4 d), and the permeability was assessed
using FITC-dextran (70 kD; anionic; Molecular Probes) as de-
scribed previously (15).
 
Leukocyte Transmigration under Flow. 
 
The parallel plate flow
chamber used for leukocyte transmigration assays has been de-
scribed previously (21). Confluent HUVEC monolayers were
treated with 25 ng/ml TNF-
 
 
 
 for 4–6 h and inserted into the flow
chamber for adhesion assays. Freshly isolated neutrophils (unstained
or stained with Alexa dye-labeled mAb) were diluted to 5 
 
 
 
 10
 
5
 
cells/ml and drawn across HUVEC monolayer at 0.25 ml/min
(calculated shear stress of 0.5 dynes/cm
 
2
 
), which avoids leukocyte
string formation and high density leukocyte adhesion that other-
wise hamper detailed analysis (20). The chamber temperature was
maintained at 37
 
 
 
C, and transmigration events were monitored us-
ing the digital recording system described in the next paragraph.
 
Live Cell Fluorescent Imaging of Leukocyte–Endothelial Transmigra-
tion under Flow. 
 
Live cell imaging was performed using Meta-
Morph 4.6 software (Universal Imaging Corp.) to control a digi-
tal imaging system coupled to an inverted microscope (model
TE2000; Nikon). Separate excitation and emission filter wheels
(Sutter Instrument Co.) combined with a [Q]polychroic beam-
splitter (Chroma Technology Corp.) allow for rapid acquisition
of different fluorescence channels. Chroma filters with appropri-
ate excitation and emission maxima were used to eliminate over-
lap between dyes (excitation 580/20, emission 630/40 for Alexa
Fluor-568; excitation 492/18, emission 530/40 for Alexa Fluor-
488). Transmitted and fluorescent light illumination was controlled
by either a Uniblitz electronic shutter (Vincent Associates) or a
shutter built in the excitation filter wheel. A high-sensitivity
cooled CCD camera (ORCA-ER; Hamamatsu Co.) acquired
images via the MetaMorph software. Live cell imaging under
flow was performed with PlanApo 20
 
 
 
 or 40
 
 
 
 differential in-
terference contrast (DIC) objectives. For time lapse two-color
experiments, sequential red, green, and DIC images were col-
lected every 5–15 s from the same field. In single color experi-
ments, only red/green channel and DIC images were collected.
Focus was manually maintained at the level of the endothelial
junctions. Images were analyzed and processed using MetaMorph
software, v4.6, and ImageJ v1.31 (http://rsb.info.nih.gov/ij).
Images were subjected to 20 blind deconvolutions (v.9.2.1; Au-
toQuant Imaging, Inc.). Images presented are representative of
multiple experiments on different days with leukocytes isolated
from different donors. 
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Ratio Imaging. 
 
Live cell imaging of neutrophil transmigra-
tion through TNF-
 
 
 
–activated HUVECs was performed as de-
scribed before. For each pair of fluorochromes, backgrounds
were digitally subtracted, and signal intensity was normalized on
adherent cells before transmigration so that red and green chan-
nels had approximately the same maximum and minimum inten-
sity levels. The normalized images were digitally divided using
the Metamorph stack arithmetic divide function and the resultant
ratio image was multiplied by an arbitrary scalar to ensure non-
fractional values. All red, green, or ratio images have been manip-
ulated as a group to allow direct comparison. The linescan data
represent average normalized intensity along a five-pixel-wide
line between the asterisks shown in the green channel (see Fig.
2). Images are representative of multiple leukocytes.
 
Laser Scanning Confocal Microscopy of Neutrophil Transmigration
under Static Conditions.
 
HUVECs (SC-2) were plated on fi-
bronectin-coated, glass-bottom 35-mm cell culture plates (Mat-
Tek) and allowed to grow to confluence. Confluent HUVEC
monolayers were stimulated with TNF-
 
 
 
 (4–6 h, 25 ng/ml), co-
incubated with neutrophils (0.5 
 
 
 
 10
 
6
 
 cells/ml) under static con-
ditions for 4 min at 37
 
 
 
C, washed to remove nonadherent neutro-
phils, and fixed for 5 min at room temperature with 4% neutral
buffered formalin to avoid movement artifact during confocal
scanning. Surface molecules on HUVEC monolayers and neutro-
phils were immunofluorescently labeled as described before, and
neutrophils in the process of transmigration were observed using a
laser scanning confocal head (Radiance 2100; Bio-Rad Laborato-
ries) attached to an inverted microscope (model TE2000; Nikon)
through a 60
 
 
 
 oil immersion objective (PlanApo, 1.4 NA; Ni-
kon). The confocal iris was set to provide a 0.5-
 
 
 
m slice thickness
and a transmigration event was scanned along the Z-axis from ba-
solateral to apical aspects in 0.5-
 
 
 
m steps. Serial sections were de-
convolved to remove out of focus light (v.9.2.1; AutoQuant Im-
aging, Inc.). A three-dimensional reconstruction of the scanned
volume was obtained and digitally sliced in the XZ plane through
the widest point of the region of transmigration to indicate a
profile view of the distribution of LFA-I or MHC-I on a transmi-
grating neutrophil (see Fig. 3). Images were analyzed in Lasersharp
2000 v4.3 (Bio-Rad Laboratories) and ImageJ v1.31 and figures
were generated in Photoshop v.7.0.
 
Quantification of JAM-A, ICAM-1, and MHC-I under PMA-acti-
vated Neutrophils. 
 
Neutrophils were activated with 100 ng/ml
PMA (5 min at 37
 
 
 
C), washed once in flow buffer, and resus-
pended in flow buffer without PMA. Activated neutrophils were
allowed to interact with TNF-
 
 
 
–treated HUVECs in a flow
chamber and imaged as described before. For endothelial JAM-A,
ICAM-1, or MHC-I imaging, red and green channels were nor-
malized as described before and overlaid with DIC. A mask cor-
responding to the DIC outline of each adherent neutrophil in a
field of view was generated. This was used to quantify the red
and green fluorescence associated with adherent neutrophils.
Neutrophil-associated fluorescence was divided by the total fluo-
rescence in a field of view to obtain a percent value. Data are rep-
resentative of three independent experiments.
 
Online Supplemental Material.
 
Fig. S1 documents that the
JAM-A mAb does not alter neutrophil adhesion or transmigra-
tion, nor affect endothelial monolayer permeability. Figs. S2 and
S3 are additional examples of neutrophil LFA-1 redistribution
and ICAM-1 redistribution during neutrophil transmigration, re-
spectively. The accompanying videos show the behavior of
ICAM-1 and LFA-1 during transmigration. Online supplemental
material is available at http://www.jem.org/cgi/content/full/jem.
20040965/DC1.
 
Results
 
Live Cell Time Lapse Visualization of LFA-1 Revealed Re-
distribution and Accumulation around the Site of Transmigra-
tion.
 
LFA-1 dynamics in live neutrophils were monitored
by immunolabeling with a fluorescent-tagged nonblocking
anti-LFA-1 mAb, TS 2/4. Neutrophils were perfused across
TNF-
 
 
 
–activated HUVEC monolayers under defined shear
flow using the live-cell, time lapse microscopy system de-
scribed in Materials and Methods. In this system, typically
50% of adherent neutrophils transmigrated over a time pe-
riod of several minutes. Analysis from paired DIC and fluo-
rescence images from multiple experiments using neutro-
phils and HUVECs from multiple donors was performed.
Fig. 1 demonstrates the typical sequence of events dur-
ing neutrophil transmigration. Neutrophils briefly roll and
Figure 1. LFA-1 redistribution during neutrophil transmigration. Time
lapse imaging of neutrophils transmigrating through 4–6-h TNF- –activated
HUVECs. (first column, red) LFA-1 distribution shown by fluorochrome-
conjugated nonblocking mAb; (second column, gray) matched DIC images;
(third column) overlay of fluorescence and DIC (DIC channel has been
digitally mapped to the blue channel, to ensure clear separation from red);
and (fourth column) the outline of significant features in fluorescence and
DIC channels. (black line) The portion of the neutrophil above the endothe-
lium; (gray lines) transmigrated portion of neutrophil under the endothelium;
and (red lines) LFA-1 relocalization. Elements of this image may be better
appreciated when viewed on screen in the online version, where subtle
differences in fluorescence intensity are more visible. Time is shown in
min:s. Bar, 10  m. 
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come to a stable arrest at, or very close to, an endothelial
junction, in agreement with previous papers (22). The time
lapse acquisition system used here was not suitable to resolve
the fast motion of rolling and, hence, we have focused on
the events that follow at and after stable arrest (Fig. 1, t 
 
  
 
0:
00). During this period of early adhesion, LFA-1 was rela-
tively evenly distributed on the neutrophil surface; although
some unevenness in LFA-1 distribution was observed, no
consistent accumulations or structures were apparent at this
early time point. On leukocytes that were subsequently go-
ing to transmigrate, a small cluster of LFA-1 appeared, ap-
parently at the contact surface of the neutrophil with the
endothelium (Fig. 1, outline column, t 
 
  
 
0:20, arrow, and
see Fig. 3; elements of this image may be better appreciated
when viewed on screen in the online version, where subtle
differences in fluorescence intensity are more visible). This
cluster grew in intensity as LFA-1 was depleted from the
rest of the leukocyte surface to contribute to it (Fig. 1, t 
 
 
 
0:35 and 0:45, arrows). The center portion of the LFA-1
cluster appeared to be relatively deficient in LFA-1, leading
to a ringlike appearance. These rings were not always com-
plete, but at least partial rings were observed in 
 
 
 
95% of
transmigration events (see Fig. S2, available at http://www.
jem.org/cgi/content/full/jem.20040965/DC1, for several
examples from a single coverslip).
As neutrophil transmigration progressed, a pseudopod
was extended through the LFA-1 ring like structure and
through the junction of tightly apposed endothelial cells
(t 
 
  
 
0:35 and 0:45). The neutrophil cell body squeezed
through the LFA-1 ring, which grew in diameter to ac-
commodate it. The ring remained at the level of the endo-
thelial surface, even while the bulk of the neutrophil had
transmigrated through it. Notably, little LFA-1 staining was
detected on the pseudopod thrust beneath the endothelium
as compared with MHC-I (Figs. 1 and 2). Eventually, the
bulk of the neutrophil passed through the endothelial junc-
tion, and the LFA-1 ring condensed to a small bright patch
at its tail, or uropod (Fig. 1, t 
 
  
 
1:00, arrow). This uropo-
dal accumulation of LFA-1 persisted even after transmigra-
tion was complete, and the neutrophil was migrating under
the endothelium, away from the site of transmigration (Fig.
1, t 
 
  
 
2:45, arrow).
As a control, next we examined the behavior of leuko-
cyte MHC-I and JAM-A, neither of which are thought to
be involved in transmigration (20, 23). Redistribution to a
ringlike structure during transmigration was specific for
LFA-1; neither neutrophil MHC-I nor JAM-A showed a
similar behavior (Fig. 2). Early after adhesion, LFA-1 colo-
calized with MHC-I over the surface of the neutrophil
(Fig. 2, t 
 
  
 
0, left). 1 min later, the neutrophil had partly
transmigrated beneath the endothelium (Fig. 2, t 
 
  
 
1:00,
arrow). As before, LFA-1 was now largely concentrated in
the ringlike structure, and was largely depleted from the
rest of the cell body above or beneath the endothelium. In
contrast, MHC-I was more evenly distributed over the
penetrating pseudopod and also over the apical portion that
had yet to pass through. Although a slight ring of MHC-I
was visible, this was variable and relatively much less visible
than the redistribution of LFA-1 as quantified by image
analysis (Fig. 2, bottom two rows, linescans). This weak ac-
cumulation of MHC-I may be due to membrane ruffling
or microdomain formation at the site of transmigration.
Another possibility is that the apparent accumulation of
MHC-I was partly due to tangential viewing of the leuko-
cyte edge from the microscope objective below. To con-
firm that the LFA-1 ring represented a specific clustering
rather than an edge effect, ratio imaging of LFA-1 and
MHC-I was performed. Here, the brightness value of the
LFA-1 signal was divided by that of MHC-I for every
pixel. At any location where LFA-1 was brighter, the cor-
responding ratio image pixel showed a bright signal. Where
MHC-I was brighter, the ratio image showed a darker sig-
nal. At t 
 
  
 
0, ratio imaging confirmed uniform distribution
of LFA-1. But during transmigration, LFA-1 was concen-
Figure 2. LFA-1 ratio imaging. (left) A neutrophil
labeled with nonblocking mAb against LFA-1 (red
channel) and MHC-I (green channel) at initial adhe-
sion (t    0) and during transmigration (t    1:00).
(white arrow) The portion of the neutrophil that has
penetrated the endothelium. (third row) The digital ratio
of red/green channels; (white areas) more LFA-1;
(darker areas) more MHC-I. Note the LFA-1 ring visible
in the second column ratio image. (right) Comparison
of leukocyte JAM-A and MHC-I did not show any
specific structures associated with transmigration. (bottom
row) A linescan of red and green channels between the
points represented by asterisks. Note the peaks of LFA-1
visible where the linescan bisects the ringlike structure
(black arrowheads). Bar, 10  m. 
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trated in a ring shape relative to MHC-I. This observation
is graphically shown in the line trace (Fig. 2, bottom). The
pixel intensity of a line between the asterisks was plotted
against the position. At t 
 
  
 
0, the LFA-1 and MHC-I
traces largely overlap. However, during transmigration,
LFA-1 forms two peaks corresponding to where the line
intersects the LFA-1 ring. Quantitatively, MHC-I rings are
less distinct. Leukocyte JAM-A and MHC-I were also
compared during early adhesion (Fig. 2, right). Both mole-
cules appeared to be evenly distributed before and during
transmigration by direct imaging as well as by quantitative
analysis (t 
 
  
 
0 and 1:00). Thus, the LFA-1 ring structure
described previously is specific.
To more directly visualize LFA-1 redistribution in com-
parison with control MHC-I, serial Z sections of fixed
neutrophils in the process of transmigration were acquired
using confocal microscopy. A vertical slice of two repre-
sentative transmigrating neutrophils are shown in Fig. 3. In
the bottom panel, two line traces are shown for each mole-
cule. One line shows intensity through the cell body (Fig.
3, dashed line, noncontact region), and the second line runs
through the contact surface (Fig. 3, solid line). LFA-1 was
enriched severalfold at the contact surface with the endo-
thelial monolayer, whereas MHC-I remained evenly dis-
tributed over the neutrophil surface.
 
Endothelial ICAM-1 Redistributes under the LFA-1 Ring.
 
Endothelial cell ICAM-1 is essential for neutrophil arrest
and transmigration (for review see reference 1). From re-
cent studies, ICAM-1 has been shown to form “docking
structures” (endothelial microvilli enriched in ICAM) that
appear to surround and engulf adherent T lymphoblasts
(24, 25). Here, we tested whether neutrophils form similar
structures in a model of robust transmigration under flow.
TNF-
 
 
 
–induced HUVECs were immunolabeled with di-
rectly conjugated nonblocking anti–ICAM-1 mAb CL23.4
(18). LFA-1–immunolabeled neutrophils were perfused
across the endothelium, and two-color live cell, time lapse
immunofluorescence was performed. A typical sequence of
Figure 3. Confocal imaging of neutrophils during transmigration.
Neutrophils were labeled with nonblocking mAb for LFA-1 (left) or
MHC class I (right) and incubated with 4–6-h TNF- –stimulated HUVECs
under static conditions. Cells were formalin (10%) fixed and imaged by
confocal microscopy. (top) Profile slices (XZ plane) of transmigrating
neutrophils, demonstrating the concentration of LFA-1 at the neutrophil–
endothelial cell interface (left) in contrast with the relatively uniform dis-
tribution of MHC-I (right). The solid line is positioned along the endo-
thelial cell interface, and the broken line is positioned across the portion of
the neutrophil that has yet to transmigrate. The intensity profiles of these
lines (bottom) show peaks of high fluorescence intensity corresponding to
LFA-1 concentration at the site of transmigration along the endothelial
surface. LFA-1 on the surface of the nontransmigrated portion of the neu-
trophil (broken line) shows low intensity peaks. In contrast, MHC class I
distribution (right) shows similar peaks corresponding to the neutrophil
surface at both the endothelial cell interface (solid line) and the nontrans-
migrated portion (broken line). Bar, 5  m.
Figure 4. ICAM-1 redistribution during neutrophil transmigration. (A,
red channel) Neutrophil LFA-1; (green channel) endothelial ICAM-1;
and (gray channel) DIC. In the merged image, DIC images have been
assigned to the blue channel to avoid overlap with red and green chan-
nels. At t   0:00, ICAM-1 is largely absent from the junctional region,
and the position of the future ICAM-1 clustering (from t   1:55) has
been marked with a broken white line. At t   1:15, white arrow shows
gap in ICAM-1 corresponding to newly formed LFA-1 ring. At t   1:55,
ICAM-1 redistribution is marked by white arrow. Bar, 10  m. (B) Rep-
resentative confocal scan of endothelial ICAM-1 during PMN transmi-
gration shows the localization of ICAM-1 in a thin section. The endothe-
lial monolayer was scanned in 0.5- m steps starting at the basolateral
plane and progressing up through the apical surface and beyond (left to
right). Confocal images demonstrate the clustering of ICAM-1 during
transmigration in a region  1  m in thickness (starting from left, panels 2
and 3). Bar, 5  m. 
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events is depicted in Fig. 4. ICAM-1 is significantly up-
regulated on HUVECs after 4-h treatment with TNF-
 
 
 
and is evenly distributed across much of the apical surface,
but appears to be somewhat excluded from the junctional
area (Fig. 4, t 
 
  
 
0:00; note broken white line in merge
panel where ICAM-1 redistribution will occur later), in
keeping with previous papers (26). Neutrophils come to
stable arrest at or close to endothelial junctions (t 
 
  
 
0:50).
As seen before, LFA-1 remains relatively evenly distributed
across the leukocyte surface, and ICAM-1 distribution re-
mains unchanged. The earliest sign of LFA-1 redistribution
is usually accompanied by a gap in the ICAM-1 staining
(Fig. 4, arrow, t 
 
  
 
1:15). During transmigration, as the
LFA-1 ring grows in diameter and intensity, ICAM-1 also
tends to show some relocalization to surround the site of
penetration (Fig. 4, t 
 
  
 
1:55). Compared with leukocyte
LFA-1, the redistribution of ICAM-1 is less robust. Never-
theless, there was frequently appreciable codistribution be-
tween the LFA-1 ring and the underlying ICAM-1 (Fig.
S3, available at http://www.jem.org/cgi/content/full/jem.
20040965/DC1). The ICAM-1 staining closes around the
neutrophil when transmigration is complete. Interestingly,
when the neutrophil is migrating beneath the endothelium,
there is no colocalization between uropodal LFA-1 and en-
dothelial ICAM-1, suggesting that LFA-1 is not binding to
ICAM-1 ligand at this stage and that other integrins are in-
volved. Confocal microscopy corroborated the clustering
of ICAM-1 during transmigration (Fig. 4 B) and, interest-
ingly, showed no evidence of ICAM-1–rich microvilli en-
gulfing the leukocyte as reported recently (25).
 
Endothelial JAM-A Also Redistributes with ICAM-1 under
the LFA-1 Ring.
 
Because LFA-1 is reported to recognize
endothelial JAM-A, and antibodies against JAM-A block a
small but significant proportion of T cell transmigration
(23), we monitored endothelial ICAM-1 and JAM-A si-
multaneously with directly conjugated nonblocking mAb
using two-color time lapse, live cell immunofluorescence
(Fig. 5). As reported previously, JAM-A was enriched at en-
Figure 5. Endothelial JAM-A redistribution during neutrophil transmi-
gration. (gray channel) DIC images; (red channel) endothelial JAM-A;
and (green channel) ICAM-1. As in Fig. 4, in the merged images DIC has
been assigned to the blue channel to avoid overlap. JAM-A and ICAM-1
redistribution is shown by white arrows at t   2:30. Bar, 10  m.
Figure 6. PMN-activated neutrophils cause LFA-1 and
ICAM-1 redistribution. Neutrophils were pretreated with
100 ng/ml PMA as described in Materials and Methods
and allowed to interact with 4–6-h TNF- –activated
HUVECs under flow. (left) Two-color imaging of LFA-1
and ICAM-1; (middle) endothelial JAM-A and ICAM-1;
and (right) endothelial JAM-A and MHC class I. To com-
pare JAM-A and ICAM-1 fluorescence, neutrophil-associated
red and green fluorescence from 365 adherent leukocytes
was quantified and compared with the total fluorescence of
the field of view to obtain a normalized intensity percent
value. For JAM-A and MHC-I, 378 adherent neutrophils
were quantified. Statistical significance was calculated using
a paired Student’s t test. Bar, 10  m. 
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dothelial junctions in our assay system (15). During neutro-
phil transmigration, this junctional JAM-A was redistributed
around the site of penetration, forming a complete or partial
ring that colocalized with the ICAM-1 ring (Fig. 5, t 
 
  
 
2:
30, arrows). Thus, both JAM-A and ICAM-1 redistribute
during neutrophil transmigration. However, these data do
not indicate whether neutrophil LFA-1 actually engages en-
dothelial JAM-A during the process of transmigration.
 
PMA-activated Leukocytes Cause Redistribution of ICAM-1
But Not JAM-A.
 
We demonstrate in the previous para-
graphs that neutrophil LFA-1 redistributes around the site
of neutrophil penetration, along with both ICAM-1 and
JAM-A at the endothelial junction. A large increase in mo-
bility of LFA-1 has been documented after PMA activation
of lymphoblasts (12) and after IL-8 stimulation of neutro-
phils (27). Although ICAM-1 is a well-characterized ligand
for LFA-1 and plays a critical role in neutrophil adhesion
and transmigration during inflammation (9, 10, 28), much
less information is available for JAM-A. Recently, endo-
thelial JAM-A was also reported to be a ligand for LFA-1
on T cells (23). To test whether activated LFA-1 itself re-
distributes or causes redistribution of its ligands in the cur-
rent system, PMA activation was used (see Materials and
Methods for activation protocol).
Untreated neutrophils came to a stable arrest at or near
the junctions of TNF-
 
 –treated endothelium and trans-
migrated the endothelium ( 50% of adherent cells trans-
migrated). In sharp contrast, PMA-treated neutrophils
adhered randomly across the endothelium, but failed to
transmigrate. Like untreated neutrophils, PMA-treated neu-
trophils showed relatively even distribution of LFA-1 upon
early adherence (unpublished data). However, if the micro-
scope objective was focused on the adherent neutrophils at
the neutrophil–endothelial cell interface, one could observe
that over a time frame of a few minutes, LFA-1 clustered at
the contact surface with the endothelium (Fig. 6, left col-
umn). This clustering took the form of a broad patch with
indistinct outlines; a few puncta of brighter fluorescence
were visible, but ringlike structures were never observed in
our studies.
Interestingly, ICAM-1 also showed clustering under
the flattened, PMA-activated neutrophils. To measure the
specificity of ligand clustering, the studies were repeated
using the two-color live cell immunofluorescence system.
Endothelial cells were labeled with directly conjugated anti–
ICAM-1 or anti–JAM-A and anti–MHC-I, using non-
overlapping fluorochromes. Neutrophil adherence caused
a slight but distinct concentration of ICAM-1, but not
JAM-A or MHC-I (Fig. 6). The degree of fluorescence
concentration relative to the fluorescence of the entire field
of view was quantified for the JAM-A/ICAM-1 or JAM-
A/MHC-I combinations. Neither JAM-A nor MHC-I
showed a significant increase under PMA-treated neutro-
phils, as compared with the overall levels, but ICAM-1
showed a statistically significant enrichment (P   0.0001).
The magnitude of this ICAM-1 enrichment was  20%
greater that MHC-I or JAM-A. Compared with LFA-1
clustering on the leukocyte, the relatively weak ICAM-1
enrichment even after this strong stimulus may correlate
with the variable appearance of ICAM-1 relocalization dur-
ing transmigration in this system.
Discussion
This paper describes the clustering of neutrophil LFA-1
into a ringlike structure at the contact surface with endo-
thelial cells, through which diapedesis occurs. On the en-
dothelial side, ICAM-1 also clustered around the site of
transmigration, although this clustering was less robust. To
resolve the temporal and spatial dynamics of this process,
we used live cell epifluorescence imaging with nonblock-
ing antibodies directed toward neutrophil LFA-1 and en-
dothelial ICAM-1. The sequence of events is depicted in
Fig. 7. Neutrophils roll on the endothelium and come to
firm adherence at or very near endothelial junctions in this
model (steps 1 and 2), in agreement with prior studies (22).
At this phase, LFA-1 is relatively evenly distributed on the
neutrophil, ICAM-1 is expressed on the endothelial apical
surface, and endothelial JAM-A is diffuse and junctional.
LFA-1 appears to concentrate at the contact surface with
endothelium, forming a small ringlike structure (step 3).
This ring grows in diameter and intensity, whereas LFA-1
from the rest of the neutrophil is recruited toward it, and a
pseudopod is inserted between the endothelial junctions as
transmigration begins (step 4). Interestingly, little if any
LFA-1 was detected on the pseudopod thrust between the
two tightly apposed endothelial cells. On the endothelial
side, a roughly matching ICAM-1 cluster is formed around
the site of penetration (not depicted for clarity). The neu-
trophil cell body squeezes across the cell border at the ring,
and LFA-1 eventually condenses into the uropod, before
transmigration is quite complete (Figs. 1 and 4). Lastly, the
neutrophil retracts its uropod under the endothelium, and
migrates away from the junction, with LFA-1 remaining in
the uropod (step 6). Concomitantly, the ICAM-1 cluster-
ing on the endothelial cell dissipates.
Figure 7. Schematic outline of neutrophil transmi-
gration through TNF- –stimulated HUVECs. (top)
Side view and (bottom) bottom view as might be seen
through inverted microscope. Neutrophil is shown as a
pink ball with LFA-1 as the red outline. Endothelial
cells are shown as flattened pale green shapes with
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Redistribution of LFA-1 into a ringlike structure appears
to be necessary for leukocyte transmigration as it was always
observed in transmigrating neutrophils, but not in cells that
remained stably adhered to the apical endothelial surface. In
addition, PMA-stimulated neutrophils, adherent to the en-
dothelial surface, exhibited LFA-1 clustering only and did
not transmigrate or form ringlike LFA-1 structures. It is
likely that the LFA-1 ring represents a population of active
integrin molecules because of the redistribution and enrich-
ment of its endothelial ligand ICAM-1, in close apposition.
Changes in affinity and avidity of LFA-1 have been docu-
mented in different systems, typically studying adhesion to
purified ligands or endothelial cells (12, 14; for review see
references 13, 27). In T cells, PKC-  (28), the small GTP-
ase Rap1, and its effector RapL (29–31) can regulate cellular
morphology and the surface distribution of LFA-1. No such
studies have been performed in neutrophils to date. By ex-
tension, reorganization of LFA-1 into a ring has been de-
scribed during the formation of the T cell–APC immune
synapse (13), although the time scale and functional signifi-
cance of immune synapse formation and the neutrophil
transmigration are distinct. Nevertheless, similar mecha-
nisms may potentially account for LFA-1 redistribution in
both cases, and similar downstream signaling events may oc-
cur as a consequence. Additional studies are necessary to
dissect whether the aforementioned molecules and/or other
pathways such as the phosphatidyl-inositol 3-kinase (14)
control neutrophil LFA-1 during transmigration.
The rapid redistribution of surface LFA-1 described
herein most likely represents changes of LFA-1 affinity and
avidity in neutrophils undergoing robust and active transmi-
gration through TNF- –activated endothelial cells. Func-
tionally, the LFA-1 ring interacting with ICAM-1 may pro-
vide a stable foundation from which neutrophil pseudopods
erupt to probe the endothelial cell–cell junctions. By exten-
sion, LFA-1 redistribution into focal ring structures (but not
to pseudopods projected beneath the endothelium) may also
serve to direct leukocyte actomyosin transmigration ma-
chinery toward the endothelium, resulting in the propulsion
of the neutrophil through the monolayer. Previous reports
have discussed mechanisms to differentiate cell movement
on a flat surface versus a three-dimensional matrix and pro-
posed an integrin-independent means of locomotion in re-
stricted spaces termed “chimneying” (32). Our observations
extend this discussion in the context of neutrophil transmi-
gration by arguing for the establishment of a highly adhesive
“ring” of contact at the site of transmigration. The redistri-
bution of LFA-1 and ICAM-1 could function as an anchor
or fulcrum used in the movement of a transmigrating neu-
trophil across the endothelium, notably in a direction per-
pendicular to any prevailing shear forces exerted by blood
flow. An additional function of such adhesion molecule
ringlike structures may involve the retention of monolayer
seal between the transmigrating leukocyte and endothelium
to prevent loss of barrier function. Indeed, prior reports us-
ing in vivo (33) and in vitro (7, 34) models have suggested
that little change occurs in vessel and endothelial cell barrier
function during transmigration of neutrophils. It will be of
interest to study whether other leukocyte types use LFA-1–
ICAM-1 or other adhesion molecule combinations (e.g.,
VLA-4–VCAM-1) in ringlike structures to transmigrate across
endothelium.
Both potential ligands for LFA-1, endothelial ICAM-1
and JAM-A, colocalized under the LFA-1 ringlike struc-
ture. However, ICAM-1 appeared to be actively recruited
toward the junctions because it was not enriched at junc-
tions before transmigration. In contrast, JAM-A is constitu-
tively present at junctions, and appeared to remain localized
around the penetrating neutrophil pseudopod, contrary to
the behavior of another junctional molecule, VE-cadherin
(3, 6). Both ICAM-1 and JAM-A may potentially interact
with LFA-1; however, our attempts to manipulate JAM-A
function by antibody blockade or adenoviral overexpres-
sion did not significantly change the rate or extent of neu-
trophil transmigration under flow (unpublished data). To
gain further insight into this process, we used PMA-acti-
vated neutrophils. PMA treatment is known to dramatically
increase LFA-1 affinity and avidity (12). Significantly, acti-
vation of neutrophils by PMA did recruit endothelial cell
ICAM-1, but not JAM-A, to the site of adhesion. This re-
sult suggests that it is a change in the LFA-1 activation state
that triggers subsequent changes in ICAM-1. Furthermore,
the PMA activation data suggest either that JAM-A is not a
LFA-1 ligand or that there is some other difference in acti-
vation or signaling that occurs during transmigration but
not during PMA-triggered adhesion. Thus, the role for
JAM-A in neutrophil transmigration remains unclear at this
time.
Previous studies have characterized the behavior of en-
dothelial and leukocyte adhesion molecules during adhe-
sion. ICAM-1 and VCAM-1 have been reported to cluster
with cytosolic linker proteins in docking structures that en-
veloped leukocytes and leukocyte cell lines after prolonged
adhesion (24). In another paper, ICAM-1 clustered in ac-
tin-rich microvilli-like membrane projections that colocal-
ized with LFA-1 during leukocyte adhesion (25). These
authors speculated that docking structures mediate leuko-
cyte engulfment by the endothelial cell, although a direct
association with leukocyte transmigration was not estab-
lished. In our assay system, we focused on neutrophils ac-
tively transmigrating at junctions of endothelial cells rather
than adherent leukocytes, transfected cell lines, and exoge-
nously added chemoattractants. Strikingly, we did not ob-
serve leukocyte engulfment by ICAM-1–containing dock-
ing structures or microvilli-like projections containing
ICAM-1 emanating from endothelium during transmigra-
tion at junctions of 4-h TNF- –activated HUVECs.
Rather, we observed the coordinated remodeling of both
leukocyte and endothelial adhesion molecules within a nar-
row plane at endothelial cell–cell junctions (Fig. 4 B).
Other likely explanations for these differences reside in the
use of the chemoattractant, platelet-activating factor in the
latter study and the use of T lymphoblasts in the former
study, which have a low rate of transmigration relative to
neutrophils and a prolonged mobility on the apical surface
that precedes transmigration. Whether or not the dockingShaw et al. 1579
structure and the LFA-1–ICAM-1 transmigration complex
are functionally related, the extensive cellular and molecu-
lar remodeling that occurs in both would imply an intimate
cross talk between both cell types during transmigration.
In summary, the current findings show that neutrophils
transiently form a ringlike cluster of LFA-1 on the leuko-
cyte contact surface with the endothelium as they rapidly
transmigrate. Simultaneously, an ICAM-1 cluster forms in
close apposition on the endothelial surface. It is possible
that other endothelial and leukocyte surface molecules are
also recruited to these clusters. We hypothesize that this
complex serves to orchestrate the endothelial and leukocyte
adhesion molecules necessary for the intricate process of
transmigration to occur.
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